Lobbyist · LDA.gov number 155420

PHILLIP HARBISON

1 reportConfirmed from the official record

PHILLIP HARBISON is named as a lobbyist in 1 lobbying report we hold, filed by 1 registrant for 1 client.

Every lobbyist

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

  • Legislative Director / Sr. Policy Advisor / Legislative Assistant, Rep. Morgan Griffith; Legislative Assistant / Special Projects Coordinator, Rep. David McKinley

Registrants and clients

Clients: ASSOCIATION FOR ACCESSIBLE MEDICINES.

Bills named where this lobbyist is listed, and how the House and the Senate voted

24 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Bills named in reports that list PHILLIP HARBISON
BillStatusHow the House and the Senate voted
H.R. 1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.IntroducedNo recorded vote in our record
H.R. 3152Patent Eligibility Restoration Act of 2025IntroducedNo recorded vote in our record
H.R. 3160PREVAIL ActIntroducedNo recorded vote in our record
H.R. 3269ETHIC ActIntroducedNo recorded vote in our record
H.R. 4132Prescription Information Modernization Act of 2025IntroducedNo recorded vote in our record
H.R. 4191MAPS ActIntroducedNo recorded vote in our record
H.R. 5811Restoring America’s Leadership in Innovation Act of 2025IntroducedNo recorded vote in our record
H.R. 6485Skinny Labels, Big Savings ActIntroducedNo recorded vote in our record
H.R. 8269CLEAR LABELS ActIntroducedNo recorded vote in our record
H.R. 9661Expedited Access to Biosimilars ActIntroducedNo recorded vote in our record
S. 43Skinny Labels, Big Savings ActIntroducedNo recorded vote in our record
S. 1041Affordable Prescriptions for Patients ActPassed the SenateNo recorded vote in our record
S. 1096Preserve Access to Affordable Generics and Biosimilars ActReported by committeeNo recorded vote in our record
S. 1302Increasing Transparency in Generic Drug Applications ActIntroducedNo recorded vote in our record
S. 1414Expedited Access to Biosimilars ActReported by committeeNo recorded vote in our record
S. 1546Patent Eligibility Restoration Act of 2025IntroducedNo recorded vote in our record
S. 1553PREVAIL ActIntroducedNo recorded vote in our record
S. 1784MAPS ActIntroducedNo recorded vote in our record
S. 2027Prescription Information Modernization Act of 2025IntroducedNo recorded vote in our record
S. 2276ETHIC ActIntroducedNo recorded vote in our record
S. 2658Medication Affordability and Patent Integrity ActReported by committeeNo recorded vote in our record
S. 3469BIOSECURE Act of 2025IntroducedNo recorded vote in our record
S. 3788CLEAR LABELS ActReported by committeeNo recorded vote in our record
S. 4280SAFE ActIntroducedNo recorded vote in our record

Issues named: Copyright/Patent/Trademark (1), Pharmacy (1).

Every report

Lobbying reports that name PHILLIP HARBISON
ClientRegistrantKind, as filedPostedReport
ASSOCIATION FOR ACCESSIBLE MEDICINESPharmacy, Copyright/Patent/TrademarkASSOCIATION FOR ACCESSIBLE MEDICINES3rd Quarter - ReportThe report on LDA.gov

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

No contribution report we hold lists a gift from this filer.

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .

2026-Q3: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote